← Back to directory

Christoph Hiemke

Researcher Next ID · RN-032030

Researcher · Medicine

Johannes Gutenberg University Mainz

Mainz, Germany

Accepting doctoral researchersFunding unknown
Works count
2,653
Citation count
20,251
H-index
64
i10-index
347

Research interests

Medicine
Neuroscience
Schizophrenia research and treatment
Treatment of Major Depression
Pharmacological Effects and Toxicity Studies
Electroconvulsive Therapy Studies
Neurotransmitter Receptor Influence on Behavior

Publications

  • An International Adult Guideline for Making Clozapine Titration Safer by Using Six Ancestry-Based Personalized Dosing Titrations, CRP, and Clozapine Levels

    Pharmacopsychiatry · 2021 · https://doi.org/10.1055/a-1625-6388

  • Consensus Guidelines for Therapeutic Drug Monitoring in Neuropsychopharmacology: Update 2017

    Pharmacopsychiatry · 2017 · https://doi.org/10.1055/s-0043-116492

  • AGNP Consensus Guidelines for Therapeutic Drug Monitoring in Psychiatry: Update 2011

    Pharmacopsychiatry · 2011 · https://doi.org/10.1055/s-0031-1286287

  • Chronic Social Stress Inhibits Cell Proliferation in the Adult Medial Prefrontal Cortex: Hemispheric Asymmetry and Reversal by Fluoxetine Treatment

    Neuropsychopharmacology · 2006 · 10.1038/sj.npp.1301275

  • CYP2D6 polymorphism and clinical effect of the antidepressant venlafaxine

    Journal of Clinical Pharmacy and Therapeutics · 2006 · 10.1111/j.1365-2710.2006.00763.x

  • Astroglial Plasticity in the Hippocampus is Affected by Chronic Psychosocial Stress and Concomitant Fluoxetine Treatment

    Neuropsychopharmacology · 2005 · 10.1038/sj.npp.1300982

  • Impact of polymorphisms of cytochrome-P450 isoenzymes 2C9, 2C19 and 2D6 on plasma concentrations and clinical effects of antidepressants in a naturalistic clinical setting

    European Journal of Clinical Pharmacology · 2004 · 10.1007/s00228-004-0766-8

  • The AGNP-TDM Expert Group Consensus Guidelines: Therapeutic Drug Monitoring in Psychiatry

    Pharmacopsychiatry · 2004 · https://doi.org/10.1055/s-2004-832687

  • A disintegrin-metalloproteinase prevents amyloid plaque formation and hippocampal defects in an Alzheimer disease mouse model

    Journal of Clinical Investigation · 2004 · 10.1172/jci20864

  • Pharmacokinetics of selective serotonin reuptake inhibitors

    Pharmacology & Therapeutics · 2000 · 10.1016/s0163-7258(99)00048-0

  • Strain Differences in Open-Field and Elevated Plus-Maze Behavior of Rats Without and With Pretest Handling

    Pharmacology Biochemistry and Behavior · 1998 · 10.1016/s0091-3057(97)00502-9

  • Pharmacokinetic Interactions of Clozapine With Selective Serotonin Reuptake Inhibitors

    Journal of Clinical Psychopharmacology · 1998 · 10.1097/00004714-199802000-00002

  • Psychosocial stress in tree shrews: Clomipramine counteracts behavioral and endocrine changes

    Pharmacology Biochemistry and Behavior · 1996 · 10.1016/0091-3057(95)02166-3

  • Elevated Levels of Clozapine in Serum After Addition of Fluvoxamine

    Journal of Clinical Psychopharmacology · 1994 · 10.1097/00004714-199408000-00011

  • Kavapyrone enriched extract fromPiper methysticum as modulator of the GABA binding site in different regions of rat brain

    Psychopharmacology · 1994 · 10.1007/bf02247480

Current projects

    No projects listed.